News

Evotec had entered into a multi-year, multi-target drug discovery alliance with Boehringer Ingelheim in 2004, to jointly identify and develop preclinical development candidates for the treatment of various

The committee’s vote followed a review of data from the Ulipristal Acetate preclinical and clinical development program, involving more than 4000 women from the US and Europe. The

As per the terms of the agreement, Bayer and OncoMed are expected to develop antibodies, protein therapeutics, and small molecules as potential novel anti-cancer stem cell therapeutics targeting

Final adoption of the opinion is expected from the European Commission later this year and subject to it being finally granted, the orphan drug status would trigger a

The treatment and enrollment in these studies is expected to restart after approval by the local regulatory authorities and ethics committees. The announcement follows a decision by the

The regulator has also advised manufacturers of liquid Vitamin D supplements that droppers accompanying these products should be clearly and accurately marked for 400 international units (IU). In

Brocacef holds stakes in companies from the field of homecare, blistering, formulation and the distribution of non-prescription products with total revenues of around EUR1b. In turn, Celesio receives

Stacked Graphene Platelet Nanofibers are grown via a patented process that decomposes carbon containing gases in the presence of metal catalyst particles, reported Cambridge Network. Strem’s nanomaterials product

Eisai Machinery and Crest Solutions said that the PharmaMarker system has been developed to meet the new coding and traceability regulations by coding, verifying and tracking up to